Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Lancet Respir Med. 2021 Sep;9(9):957-968. doi: 10.1016/S2213-2600(21)00237-X. Epub 2021 Jun 18.
Lancet Respir Med. 2021.
PMID: 34147142
Free PMC article.
Clinical Trial.
Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Duijvelaar E, Vanhove A, Schippers JR, Smeele PJ, de Man FS, Pinto Y, Aman J, Bogaard HJ; CounterCOVID Collaborative Group.
Duijvelaar E, et al.
J Cardiovasc Pharmacol. 2022 Dec 1;80(6):783-791. doi: 10.1097/FJC.0000000000001344.
J Cardiovasc Pharmacol. 2022.
PMID: 35976136
Clinical Trial.
Item in Clipboard
Long-term clinical outcomes of COVID-19 patients treated with imatinib.
Duijvelaar E, Schippers JR, Smeele PJ, de Raaf MA, Vanhove ALEM, Blok SG; CounterCOVID Collaborative Group; Twisk JWR, Vonk Noordegraaf A, de Man FS, Bogaard HJ, Aman J.
Duijvelaar E, et al. Among authors: vanhove alem.
Lancet Respir Med. 2022 Apr;10(4):e34-e35. doi: 10.1016/S2213-2600(22)00052-2. Epub 2022 Feb 17.
Lancet Respir Med. 2022.
PMID: 35183270
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.